Does prostate size impact upon perioperative outcomes associated with photoselective vaporization of the prostate using the 180W lithium triborate laser?

Urology Annals

Volumn 7, Issue 1, 2015, Pages 17-20

  West, Kellie E ^a   Woo, Henry H ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Benign prostatic hyperplasia; laser prostatectomy; photoselective vaporization prostate

Indexed keywords

180W LITHIUM TRIBORATE LASER; AGED; ARTICLE; CATHETERIZATION; HOSPITAL DISCHARGE; HUMAN; LASER; LASER SURGERY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PHOTOSELECTIVE VAPORIZATION OF THE PROSTATE; PROSTATE HYPERTROPHY; PROSTATE SIZE; RETROSPECTIVE STUDY; TRANSRECTAL ULTRASONOGRAPHY;

EID: 84921038501     PISSN: 09747796     EISSN: 09747834     Source Type: Journal    
DOI: 10.4103/0974-7796.148579     Document Type: Article

References (11)

1. Bachmann A, Muir GH, Collins EJ, Choi BB, Tabatabaei S, Reich OM, et al. 180-W XPS GreenLight laser therapy for benign prostate hyperplasia: Early safety, efficacy, and perioperative outcome after 201 procedures. Eur Urol 2012;61:600-7.
2. Chung AS, Chabert C, Yap HW, Lam J, Awad N, Nuwayhid F, et al. Photoselective vaporization of the prostate using the 180W lithium triborate laser. ANZJ Surg 2012;82:334-7.
3. Thangasamy IA, Chalasani V, Bachmann A, Woo HH. Photoselective vaporisation of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: A systematic review with meta-analysis from 2002 to 2012. Eur Urol 2012;62:315-23.
4. McVary KT, Roehrborn C, Avins A, Barry MJ, Bruskewitz RC, Donnell RF, et al. Clinical practice guideline: Management of BPH 2010.American Urological Association website. Available from: http://www.auanet.org/common/pdf/education/clinical-guidance/Benign-Prostatic-Hyperplasia.pdf. [Last accessed on 2013 Sept 30].
5. Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, et al. Guidelines on the Management of Male Lower Urinary Tract Symptoms (LUTS), Incl. Benign Prostatic Obstruction (BPO) 2012. European Association of Urology website. Available from: http://www.uroweb.org/gls/pdf/12-Male-LUTS-LR.pdf. [Last accessed on 2013 Sept 30].
6. Campbell NA, Chung AS, Yoon PD, Thangasamy I, Woo HH.Early experience photoselectivevaporisation of the prostate using the 180W lithium triborate and comparison with the 120W lithium triborate laser. Prostate Int 2013;1:42-5.
7. Woo H, Reich O, Bachmann A, Choi B, Collins E, de la Rosette J, et al. Outcome of GreenLight HPS 120-Wlaser therapy in specific patient populations: Those in retention, on anticoagulants, and with large prostates. Eur Urol Suppl 2008;7:378-83.
8. Woo HH. Photoselective vaporization of the prostate using the 120-W lithium triborate laser in enlarged prostates (>120 cc). BJ UInt 2011;108:860-3.
9. Bachmann A, Tubaro A, Barber N, d'Ancona F, Muir G, Witzsch U, et al. 180-W XPS GreenLight Laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European multicentrerandomised trial-the GOLIATH study. Eur Urol 2014;65:931-42.
10. Bachmann A, Woo HH, Wyler S. Laser prostatectomy of lower urinary tract symptoms due to benign prostate enlargement: A critical review of evidence. Curr Opin Urol 2012;22:22-33.
11. Madersbacher S. After three randomised controlled trials comparing 120-W high-performance-system potassium-titanyl-phosphate laser vaporisation to transurethral resection of the prostate (TURP), is this procedure finally first-line, outdated, or still not surpassing TURP? Eur Urol 2012;61:1174-7.